CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

David J. Allsop - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

David J. Allsop

OPENALEX: A5105933407↗

Affiliations

Organizations

National Centre for Clinical Research on Emerging Drugsauthorship · AU South Eastern Sydney Local Health Districtauthorship · AU The University of Sydneyauthorship · AU UNSW Sydneyauthorship · AU

Public evidence

3 connected articles

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).2018 · Europe PMC Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMC Quantifying the Clinical Significance of Cannabis Withdrawal2012 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.